Health care executive coaches explain why leaders aren't feeling holly-jolly this year. Plus, Shiv Rao on Abridge's next moves.

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. , today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin) for oral suspension, a ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ...

At the time, Humana was in the midst of a nearly $2 billion expansion of the clinics across 15 states, and CEO Bruce ...

Humana said on Tuesday that George Renaudin will step down as president of its insurance segment and named Amazon healthcare ...

Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs for employers. Cuban, an entrepreneur, businessman and TV personality who ...

Credit rating agency Fitch on Monday downgraded the credit ratings of insurance giant Humana along with various subsidiaries.

Humana is again trying to win its lawsuit against the Centers for Medicare and Medicaid Services over its star ratings designation. On Wednesday, Nov. 26, the day before Thanksgiving, Humana filed a ...

For the hefty price of $1 million, plus at least $15,000 in fees, you can get permanent residency in the United States.

Mount Carmel Health System has reached a multi-year agreement with Medicare Advantage provider Humana as open enrollment is underway. The deal formalized on Oct. 1, but Mount Carmel Health System ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted ...

Humana will appeal a court loss over the Medicare Advantage star ratings, according to a filing issued Tuesday. The insurer filed a notice that it will appeal the District Court ruling to the Fifth ...